Jefferies Downgrades Six Indian IT Companies Over Concerns About the Impact of Artificial Intelligence
Jefferies downgraded six Indian IT companies, citing that the disruption brought by AI tools is expected to lead to structural changes in business operations.
Jefferies downgraded Tata Consultancy Services (TCS), India's largest IT exporter, from "Hold" to "Underperform"; downgraded Infosys and HCLTech from "Buy" to "Hold"; downgraded LTIMindtree and Hexaware Technologies to "Underperform"; and downgraded Mphasis to "Hold". The Nifty IT Index in India fell 1.1%, making it the worst-performing sector among major industries.
Jefferies stated that AI may shift the structure of IT business towards consulting and implementation, while compressing the scale of managed services. This will not only increase the cyclical volatility of the industry but also require companies to adjust their talent structures and operating models, thereby intensifying risks.
Editor: Wang Yongsheng
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BoJ’s Takata calls for nimble, data-dependent rate hikes rather than a fixed pace
AI Infrastructure Stocks Shed $4.2 Trillion—Is the “Shovel Seller Feast” Over?
Since June, Caterpillar has dropped by 44%, and Oklo has plummeted by 49%. Analysts point to the root cause: investors have been speculating on traditional industrial stocks as growth stocks, resulting in severely overvalued prices. Another key factor behind the sell-off is the uncertainty of data center regulatory policies following the U.S. midterm elections. The fundamentals remain resilient—Caterpillar has a backlog of orders totaling $78 billion, and several companies have secured revenue growth through 2027.

Johnson & Johnson (JNJ.US) plans to spend $3.4 billion to acquire Ollin, expanding its presence in the retinal disease treatment sector.
According to sources familiar with the matter, Johnson & Johnson may announce a deal as early as Monday to acquire Texas-based biotech company Ollin Biosciences for up to $3.4 billion.
As market forces battle each other, the yen is caught in a tug-of-war between bulls and bears! Goldman Sachs bets on a comeback while Morgan Stanley predicts a fall to 162
As the USD/JPY exchange rate approaches the key 160 level again, Morgan Stanley and Goldman Sachs have expressed sharply divergent views on the yen’s outlook. This highlights that forecasting the yen’s exchange rate is becoming increasingly challenging amid multiple conflicting forces.

